Summary
Edwards Lifesciences Corporation (EW) filed an 8-K on April 22, 2004, to report its financial results for the first quarter of 2004. The filing primarily consists of a press release detailing these results. Investors should note that while the press release is attached as an exhibit, only the first two paragraphs and pages 6 through 11 are considered 'filed' for regulatory purposes, with the rest being furnished. This filing serves as the primary disclosure mechanism for the company's performance in the first quarter of the fiscal year 2004.
Key Highlights
- 1Edwards Lifesciences filed an 8-K on April 22, 2004, to disclose Q1 2004 financial results.
- 2The core of the filing is a press release containing the company's first-quarter financial performance.
- 3The report specifies which parts of the press release are considered officially 'filed' with the SEC versus 'furnished'.
- 4This filing provides an early look at the company's operational and financial standing for the beginning of 2004.
- 5Investors can find key financial metrics and operational updates within the attached press release (Exhibit 99.1).
Frequently Asked Questions
The main purpose of this 8-K filing is to publicly disclose Edwards Lifesciences' financial results for the first quarter of 2004, as reported in a press release.
The detailed financial results are provided in Exhibit 99.1, which is the press release dated April 22, 2004, reporting on Edwards' first quarter 2004 financial performance.
No, only the first two paragraphs of the press release and pages 6 through 11 are considered 'filed' under the Securities Exchange Act of 1934. The rest of the press release is 'furnished'.
This report covers the financial results for the first quarter of 2004, ending on March 31, 2004.